https://orcid.org/0000-0001-5055-6216
Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Christine M. Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Andy He & Julie Vanderpoel. (2024) Cost of genetic testing, delayed care, and suboptimal treatment associated with polymerase chain reaction versus next-generation sequencing biomarker testing for genomic alterations in metastatic non-small cell lung cancer. Journal of Medical Economics 27:1, pages 292-303.
Read now
Read now
David Proudman, Nicholas C. DeVito, Suzanne Belinson, Mina Alsaraf Allo, Eric D. Morris, James Signorovitch & Anuj K. Patel. (2022) Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use. Journal of Medical Economics 25:1, pages 817-825.
Read now
Read now
Articles from other publishers (13)
Mo Yang, Erin Mandal, Frank X. Liu, Richard M. O’HaraJrJr, Beth Lesher & Rachel E. Sanborn. (2024) Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments. Frontiers in Oncology 13.
Crossref
Crossref
Jiamin Lu, Yuqian Feng, Kaibo Guo, Leitao Sun, Shanming Ruan & Kai Zhang. (2024) Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 150:1.
Crossref
Crossref
Soeren M. Buchholz, Nelia Nause, Ute König, Johanna Reinecke, Benjamin Steuber, Christoph Ammer-Herrmenau, Kirsten Reuter-Jessen, Hanibal Bohnenberger, Lorenz Biggemann, Friederike Braulke, Albrecht Neesse, Volker Ellenrieder, Philipp Ströbel, Marius Adler & Alexander König. (2023) Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology. Journal of Personalized Medicine 13:12, pages 1701.
Crossref
Crossref
Yi‐Long Wu, Shun Lu, Ying Cheng, Qing Zhou, Hai‐Yan Tu, Qing‐Hua Zhou, Lv‐Hua Wang, Li Zhang, Jian‐Ying Zhou, Cheng Huang, Ming Chen, Cheng‐Ping Hu, Shao‐Kun Chuai, Xiao‐Nan Wang, Xiao‐Qing Liu, Ji‐Wei Liu, Peng‐Hui Zhou, Wei‐Zhi Chen, Ling‐Hua Yan, Yun‐Peng Liu, An‐Wen Liu, Xu‐Chao Zhang, Hui Li, Rong‐Rong Chen, Dong‐Mei Lin, Cong‐Ying Xie, Zheng‐Fei Zhu, Hui‐Ying Liang, Yong Song, Xiao‐Rong Dong, Ming‐Fang Zhao, Gui‐Bin Qiao, Jiu‐Wei Cui, Zi‐Ming Li, Zhi‐Jie Wang, Xiao‐Yuan Chen, Nong Yang, Gen Lin, Pan‐Wen Tian, Yun Fan, Qi‐Bin Song, Yuan Chen, Jian‐Chun Duan, Jia‐Lei Wang, Bo Zhu, Bu‐Hai Wang, Jun Zhao, Qi‐Tao Yu, Li‐Feng Wang, Hai‐Bo Zhang, Jie Hu, Rui Ma, Tong‐Mei Zhang, Jie Lin, Qian Chu, Sheng‐Xiang Ren, Yu Yao, Lin Wu, Hui‐Juan Wang, Fang Wu, Wen‐Zhao Zhong, Yi Hu, Ke‐Neng Chen, Jian Zhao, Li Zhang, Fan Yang, Qun Wang, Dong‐Sheng Yue, Jian‐Ya Zhou, Peng Shen, Jia‐Tao Zhang, Xiao‐Long Yan, Mei‐Juan Huang, Wei‐Neng Feng & Li Li. (2023) Uncommon/rare oncogenic drivers in non‐small cell lung cancer: Consensus and contention. Medicine Advances 1:4, pages 293-305.
Crossref
Crossref
Caicun ZhouKe-Jing TangByoung Chul ChoBaogang LiuLuis Paz-AresSusanna ChengSatoru KitazonoMuthukkumaran ThiagarajanJonathan W. Goldman, Joshua K. SabariRachel E. SanbornAaron S. Mansfield, Jen-Yu HungMichael BoyerSanjay PopatJosiane Mourão DiasEnriqueta FelipMargarita MajemMahmut GumusSang-we KimAkira OnoJohn XieArchan BhattacharyaTrishala AgrawalS. Martin ShreeveRoland E. KnoblauchKeunchil ParkNicolas Girard. (2023)
Amivantamab plus Chemotherapy in NSCLC with
EGFR
Exon 20 Insertions
. New England Journal of Medicine 389:22, pages 2039-2051.
Crossref
Crossref
Kerri Cabrera, Jeffrey Gole, Bryan Leatham, Matthew J. Springer, Molly Smith, Leah Herdt, Lucien Jacky & Bradley A. Brown. (2023) Analytical Performance and Concordance with Next-Generation Sequencing of a Rapid, Multiplexed dPCR Panel for the Detection of DNA and RNA Biomarkers in Non-Small-Cell Lung Cancer. Diagnostics 13:21, pages 3299.
Crossref
Crossref
Lydia Formanti Alonso, Lidia Atienza Cuevas, Raquel Romero García, Javier Mohigefer Barrera, Juan Jesús del Río Ignacio, Antonio Santisteban Espejo, Irene Bernal Florindo, Inmaculada Catalina Fernández & Marcial García Rojo. (2023) Estudio de variantes genéticas en 169 pacientes de cáncer de pulmón no microcítico. Revista Española de Patología 56:4, pages 233-242.
Crossref
Crossref
Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith & Rhodri Saunders. (2023) Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis. Journal of Health Economics and Outcomes Research, pages 111-118.
Crossref
Crossref
Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith & Rhodri Saunders. (2023) Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis. Journal of Health Economics and Outcomes Research 10:1.
Crossref
Crossref
Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J. Francisco García, David Carcedo & Enrique de Álava. (2023) Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO Precision Oncology:7.
Crossref
Crossref
Thomas Hofmarcher, Chiara Malmberg & Peter Lindgren. (2023) A global analysis of the value of precision medicine in oncology – The case of non-small cell lung cancer. Frontiers in Medicine 10.
Crossref
Crossref
Brandon S. Sheffield, Kiefer Eaton, Bruno Emond, Marie-Hélène Lafeuille, Annalise Hilts, Patrick Lefebvre, Laura Morrison, Andrea L. Stevens, Emmanuel M. Ewara & Parneet Cheema. (2023) Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current Oncology 30:2, pages 2348-2365.
Crossref
Crossref
Miguel A. Ortega, Leonel Pekarek, Fátima Navarro, Oscar Fraile-Martínez, Cielo García-Montero, Miguel Ángel Álvarez-Mon, Raúl Diez-Pedrero, María del Carmen Boyano-Adánez, Luis G. Guijarro, Silvestra Barrena-Blázquez, Ana M. Gómez-Lahoz, Sergio Haro, Mónica Arroyo, Jorge Monserrat, Miguel A. Saez & Melchor Alvarez-Mon. (2023) Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer. Journal of Personalized Medicine 13:2, pages 167.
Crossref
Crossref